PROphet
®
PROphetNSCLC
®
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphetNSCLC
®
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
September 20, 2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Original source
here.
Recent news
December 14, 2025
“Younger people are getting cancer more and more. We have to make kinder medicines.”
Read more
December 8, 2025
OncoHost named ‘Technology Solution of the Year’ at 2025 Merit Awards for Healthcare
Read more
December 4, 2025
OncoHost Wins Gold for AI-Powered Cancer Prediction Platform
Read more
December 4, 2025
OncoHost Named Gold Winner in 2025 Merit Awards for Healthcare - Technology Solution of the Year
Read more
November 7, 2025
OncoHost wins Proteomics Innovation of the Year for PROphet platform
Read more
November 6, 2025
Israeli Startup OncoHost Wins Global Award for Proteomics Innovation
Read more
Read all news
